Evaluation of selected lipid parameters and blood pressure in ethnically-homogenous population of middle-aged persons, depending on gender, age and body mass

• Authors: Adam Buciński , Jerzy Romaszko , Ryszard Targoński , Leszek Cichowski , Ewa Romaszko , Andrzej Zakrzewski , Małgorzata Wnuk
• Languages of publication: EN

Abstracts

EN

The study is a retrospective analysis of data obtained from a cardiovascular disease prevention program financed by the National Health Fund (Poland). The aim of the study was to evaluate the population to demonstrate the prevalence of favourable and unfavourable lipid parameters and blood pressure values depending on age and BMI. A total of 2,616 subjects were included in the study (811 men and 1805 women aged between 35 and 55 years of age) who perceived themselves as completely healthy individuals and in whom no cardiovascular disease or diabetes mellitus had been diagnosed. We evaluated blood pressure values, body weight, height, BMI, fasting glucose, total cholesterol, triglycerides, HDL and LDL in the serum of venous blood. The above-mentioned parameters were compared in women and men depending on BMI and age. It was demonstrated that the epidemiological situation of women in the analysed age group, regardless of the studied parameter and method of its evaluation, is much more favourable than that of men. We have demonstrated that evaluation of the analysed lipid parameters and blood pressure should be performed with consideration to gender and age. Otherwise conclusions may be obtained which are not satisfied by 75-95% of the population in a given age group. Obesity was highlighted as a factor triggering further lipid disturbances and blood pressure increase.

Keywords

EN

Biomedical statistics; Cardiovascular disease; Risk factors; Lipid parameter; Positive health outcomes

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2010
• Volume: 5
• Issue: 4
• Pages: 486-494

Dates

published

1 - 8 - 2010

online

30 - 5 - 2010

Contributors

author

Adam Buciński

• Department of Biopharmacy, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, 85-094, Bydgoszcz, Poland

author

Jerzy Romaszko

• NZOZ Pantamed Sp z o.o. in Olsztyn, 10-461, Olsztyn, Poland

author

Ryszard Targoński

• Department of Nursing, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, 10-561, Olsztyn, Poland

author

Leszek Cichowski

• Cardiology and Internal Diseases Ward, City Complex of Hospitals in Olsztyn, 10-045, Olsztyn, Poland

author

Ewa Romaszko

• NZOZ Atarax in Olsztyn, 10-117, Olsztyn, Poland

author

Andrzej Zakrzewski

• Warminsko-Mazurski Provincial Branch of the National Health Fund, 10-561, Olsztyn, Poland

author

Małgorzata Wnuk

• Department of Biopharmacy, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, 85-094, Bydgoszcz, Poland

References

• [1] Atlas of Heart Disease and Stroke. WHO, 2004; Sept.
• [2] Conroy R.M., Pyorala K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al., SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J., 2003, 24, 987–1003 http://dx.doi.org/10.1016/S0195-668X(03)00114-3[Crossref]
• [3] Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al., INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 2004, 364, 937–952 http://dx.doi.org/10.1016/S0140-6736(04)17018-9
• [4] Stevens V.J., Corrigan S.A., Obarzanek E., Bernauer E., Cook N.R., Hebert P., et al., Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med., 1993, 153, 849–858 http://dx.doi.org/10.1001/archinte.153.7.849
• [5] Targoński R., Buciński A., Romaszko J., Zakrzewski A., Romaszko E., Analysis of selected risk factors of coronary artery disease in a healthy population aged 35–55 years. Kardiol Pol., 2007, 65, 1216–1222
• [6] Gostynski M., Gutzwiller F., Kuulasmaa K., Döring A., Ferrario M., Grafnetter D., WHO MONICA Project., Analysis of the relationship between total cholesterol, age, body mass index among males and females in the WHO MONICA Project. Int J Obes Relat Metab Disord., 2004, 28, 1082–1090 http://dx.doi.org/10.1038/sj.ijo.0802714[Crossref]
• [7] Behn A., Ur E., The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol., 2006, 21, 353–360 http://dx.doi.org/10.1097/01.hco.0000231406.84554.96[Crossref]
• [8] Hubert H.B., Feinleib M, McNamara P.M., Castelli W.P., Obesity as an independent risk factor of cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation, 1983, 67, 968–977
• [9] Brown C.D., Higgins M., Donato K.A., Rohde F.C., Garrison R., Obarzanek E., et al., Body Mass Index and the Prevalence of Hypertension and Dyslipidemia. Obesity Research, 2000, 8, 605–619 http://dx.doi.org/10.1038/oby.2000.79[Crossref]
• [10] Drøyvold W.B., Midthjell K., Nilsen T.I., Holmen J., Change in body mass index and its impact on blood pressure: a prospective population study. Int J Obes (Lond). 2005, 29, 650–655 http://dx.doi.org/10.1038/sj.ijo.0802944[Crossref]
• [11] Narodowy program zdrowia. Ministerstwo Zdrowia Polska http://www.mz.gov.pl
• [12] Hayman L.L., Williams C.L., Daniels S.R., Steinberger J., Paridon S., Dennison B.A., et al., Cardiovascular Health Promotion in the Schools: A Statement for Health and Education Professionals and Child Health Advocates From the Committee on Atherosclerosis, Hypertension, and Obesity in Youth (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 2004, 110, 2266–2275 http://dx.doi.org/10.1161/01.CIR.0000141117.85384.64[Crossref]
• [13] Breslow L., Health Measurement in the Third Era of Health. American Journal of Public Health, 2006, 96, 17–19 http://dx.doi.org/10.2105/AJPH.2004.055970[Crossref]
• [14] Friedewald W.T., Levy R.I., Fredrickson D.S., Estimationof the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clinical Chemistry, 1972, 18, 499–502
• [15] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486–2497 http://dx.doi.org/10.1001/jama.285.19.2486[Crossref]
• [16] Joint National Committee: The Sixth Report of the Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure. (JNC VI) Arch Int Med., 1997, 157, 2413 http://dx.doi.org/10.1001/archinte.157.21.2413[Crossref]
• [17] Shapiro S.S., Wilk M.B., Chen H.J., A comparative study of various tests of normality. Journal of the American Statistical Association, 1968, 63, 1343–1372 http://dx.doi.org/10.2307/2285889[Crossref]
• [18] Brown M.B., Forsythe A.B., Robust tests for the equality of variances. Journal of the American Statistical Association., 1974, 69, 264–267 http://dx.doi.org/10.2307/2285540[Crossref]
• [19] Winer B.J., Brown D.R., Michels K.M., Statistical principals in experimental design. (3rd ed.). New York: McGraw-Hill. 1991
• [20] Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences (2nd ed.) New York: McGraw-Hill, 1988
• [21] Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al., Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001. JAMA, 2003, 289, 76–79 http://dx.doi.org/10.1001/jama.289.1.76[Crossref]
• [22] Stramba-Badiale M., Fox K.M., Priori S.G., Collins P., Daly C., Graham I., et al., Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. European Heart Journal, 2006, 27, 994–1005 http://dx.doi.org/10.1093/eurheartj/ehi819[Crossref]
• [23] Mosca L., Appel L.J., Benjamin E.J., Berra K., Chandra-Strobos N., Fabunmi R.P., et al., American Heart Association. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation, 2004, 109, 672–693 http://dx.doi.org/10.1161/01.CIR.0000114834.85476.81[Crossref]
• [24] Kannel W.B., Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J, 1987, 114, 413–419 http://dx.doi.org/10.1016/0002-8703(87)90511-4[Crossref]
• [25] Gregg W.E., Cheng Y.J., Cadwell B.L., Imperatore G., Williams D.E., Flegal K.M., et al., Secular Trends in Cardiovascular Diseases Risk Factors According to Body Mass Index in US Adults. JAMA, 2005, 293, 1868–1874 http://dx.doi.org/10.1001/jama.293.15.1868[Crossref]
• [26] Haenle M.M., Brockmann S.O., Kron M., Bertling U., Mason R.A, Steinbach G., et al., Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults. BMC Public Health, 2006, 18, 233 http://dx.doi.org/10.1186/1471-2458-6-233[Crossref]
• [27] Tykarski A., Posadzy-Małczyńska A., Wyrzykowski B., Kwaśniewska M., Pająk A.. Tendera M., et al., Rozpowszechnienie nadciśnienia tętniczego oraz skuteczność jego leczenia u dorosłych mieszkańców naszego kraju. Wyniki programu WOBASZ. Kardiol Pol, 2005, 63, 614–618
• [28] Pająk A., Wiercińska E., Polakowska M., Kozakiewicz K., Kaczmarczyk-Chałas K., Tykarski A., et al., Rozpowszechnienie dyslipidemii u mçżczyzn i kobiet. Wyniki programu WOBASZ. Kardiol Pol., 2005, 63, 620–S625
• [29] MacDonald S., Joffres M.R., Stachenko S., Horlick L., Fodor G., Multiple cardiovascular disease risk factors in Canadian adults. Can Med Assoc J., 1992, 146, 2021–2029
• [30] Rohrer J.E., Anderson G.J., Furst J.W., Obesity and pre-hypertension in family medicine: Implications for quality improvement. BMC Health Serv Res., 2007, 21, 212 http://dx.doi.org/10.1186/1472-6963-7-212[Crossref][WoS]
• [31] Labreuche J, Touboul PJ, Amarenco P. Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies. Atherosclerosis, 2009, 203, 331–345 http://dx.doi.org/10.1016/j.atherosclerosis.2008.08.040[WoS][Crossref]

Identifiers

DOI

10.2478/s11536-010-0025-6